Cell-Based Assays: World Market Prospects 2012-2022 Bharat Book introduces a report " Cell-Based Assays " Our report shows you how their use is increasing in drug discovery and development.
BigNews.Biz - Aug 08,2012 - What does the future hold for cell-based assays in pharma? Visiongain's report shows you potential revenues and other trends, with data, forecasts and discussions.
Our study analyses products and services for cell-based testing. It covers activities of product developers and pre-clinical contract research organisations.
You discover sales predictions to 2022 at world market, main submarket and national levels. Find potential revenues for products and services.
Also, you receive discussions of many companies in the cell assay industry, seeing their activities and outlooks. http://www.bharatbook.com/healthcare-market-research-reports/cell-based-assays-world-market-prospects-2012-2022.html
Companies featured include the following:
BD Biosciences
Life Technologies
PerkinElmer
Beckman Coulter
Evotec
GE Healthcare
Thermo Fisher Scientific
Covance
PPD
Charles River Laboratories
MD Biosciences.
Looking ahead to 2022, many commercial opportunities exist for cell-based testing. Our report gives you business research and analysis there.
Where are cellular assays heading? Greater need for cellular information earlier in pre-clinical product development stimulates demand for the tests. Our report shows you how their use is increasing in drug discovery and development.
Which developmental processes will benefit most from cell assays? This decade, drug screening and toxicity testing will be important applications for cell-based products and services, our analysis shows.
At present, half of all assays used in pharmaceutical development are cell-based. Miniaturisation and automation are important. We find wide scope for developing the systems and applications from 2012 to 2022, seeing many opportunities.
What are the limitations of cell-based assays? For their potential to be achieved, challenges must be tackled. Systems such as 3D assays will allow for more-accurate simulation of in vivo conditions in cell cultures. Our report explains.
Visiongain's study provides data, analysis and opinion aiming to benefit your research, calculations and presentations. You find answers now in our work.
Revenue forecasts, market shares, developmental trends and discussions
In our report you find revenue forecasting, growth rates and market shares. Also, you have qualitative analyses (SWOT and STEP) and discussion of technologies, existing and in development. You receive 74 tables and charts and two research interviews.
Advantages of Cell-Based Assays: World Market Prospects 2012-2022 for your work
In particular, this study gives you the following knowledge:
Find potential revenues to 2022 for the world market and submarkets
See market forecasting to 2022 for US, Japan, EU5, China and India
Assess leading companies, discovering activities and outlooks
Review technological developments, assessing trends and prospects
Investigate competition and opportunities influencing revenues
Find out what will stimulate and restrain the industry and market
Analyse pharma R&D spending by stage and find an overall forecast to 2022
View opinions from our survey, receiving detailed interviews.
There, you find a distinctive mix of quantitative and qualitative analyses with independent predictions. Without our report, you could miss out on information that your competitors are using.
We analyse developments and prospects in cellular testing, helping you to stay ahead.
Gain business research and analysis for cell-based assays
Our study is for everybody needing industry and
.gif)
